Bisoprolol/amlodipine combination therapy improves blood pressure control in patients with essential hypertension following monotherapy failure

References

• A global brief on hypertension. 2013. World Health Organization (WHO). Available at: http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/[Last accessed August 2015]
   Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27:2121-58
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72
   PubMed Web of Science ®Google Scholar
• Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375-414
   PubMed Web of Science ®Google Scholar
• Zanchetti A. Contribution of fixed low-dose combinations to initial therapy in hypertension. Eur Heart J 1999;20(Suppl 1):L5-9
   Google Scholar
• Klein G. German MC Study Group. Combination therapy with felodipine and metoprolol compared with captopril and hydrochlorothiazide. Blood Press 1998;7:308-12
   PubMedGoogle Scholar
• Barrios V, Brommer P, Haag U, et al. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study. Clin Drug Investig 2009;29:427-39
   PubMed Web of Science ®Google Scholar
• Fox K, Garcia MA, Ardissino D, et al. [Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris]. Kardiol Pol 2006;64:823-80
   PubMedGoogle Scholar
• Nuttall SL, Routledge HC, Kendall MJ. A comparison of the beta1-selectivity of three beta1-selective beta-blockers. J Clin Pharm Ther 2003;28:179-86
   PubMed Web of Science ®Google Scholar
• Smith C, Teitler M. Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors. Cardiovasc Drugs Ther 1999;13:123-6
   PubMed Web of Science ®Google Scholar
• Murdoch D, Heel RC. Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 1991;41:478-505
   PubMed Web of Science ®Google Scholar
• Wellstein A, Palm D, Belz GG. Affinity and selectivity of beta-adrenoceptor antagonists in vitro. J Cardiovasc Pharmacol 1986;8(Suppl 11):S36-S40
   Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press 2014;23:3-16
   PubMed Web of Science ®Google Scholar
• Czarnecka D, Koch EM, Gottwald-Hostalek U. Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients. Curr Med Res Opin 2015;31:875-81
   PubMed Web of Science ®Google Scholar
• Mehta S, Shah M, Shah A, et al. Efficacy and tolerability of a fixed dose combination of amlodipine and bisoprolol in essential hypertension. Indian Practitioner 2005;58:751-9
   Google Scholar
• Rana R, Patil A. Efficacy and safety of bisoprolol plus amlodipine fixed dose combination in essential hypertension. Indian Practitioner 2008;61:225-34
   Google Scholar
• Shirure PA, Tadvi NA, Bajait CS, et al. Comparative effect of fixed dose combination of amlodipine + bisoprolol versus amlodipine and bisoprolol alone on blood pressure in stage-2 essential hypertensive patients. Int J Med Res Health Sci 2012;1:13-19
   Google Scholar
• Chesnikova AI, Safronenko VA, Kolomatskaia OE. [Evaluating the effectiveness of a fixed combination of amlodipine and bisoprolol in ambulatory patients with arterial hypertension and ischemic heart disease]. Kardiologiia 2014;54:17-23
   PubMed Web of Science ®Google Scholar
• American Heart Association. Advanced Cardiac Life Support (ACLS) Bradycardia Algorithm. Available at: https://acls-algorithms.com/bradycardia/and https://www.acls.net/acls-bradycardia-algorithm.htm [Last accessed April 2016]
   Google Scholar
• Abdul Rahman AR, Reyes EB, Sritara P, et al. Combination therapy in hypertension: an Asia-Pacific consensus viewpoint. Curr Med Res Opin 2015;31:865-74
   PubMed Web of Science ®Google Scholar
• Gradman AH, Basile JN, Carter BL, et al. Combination therapy in hypertension. J Am Soc Hypertens 2010;4:90-8
   PubMed Web of Science ®Google Scholar
• Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326:1427
   PubMed Web of Science ®Google Scholar
• Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009;122:290-300
   PubMed Web of Science ®Google Scholar
• Struijker-Boudier HA, Ambrosioni E, Holzgreve H, et al. The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials? Int J Clin Pract 2007;61:1592-602
   PubMed Web of Science ®Google Scholar
• National Heart Foundation of Australia. Guide to management of hypertension 2008: assessing and managing raised blood pressure in adults. Updated December 2010. Available at: http://www.heartfoundation.org.au/information-for-professionals/Clinical-Information/Pages/hypertension.aspx [Last accessed September 2015]
   Google Scholar
• Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009;32:3-107
   PubMed Web of Science ®Google Scholar
• Paravastu SC, Mendonca DA, Da Silva A. Beta blockers for peripheral arterial disease. Cochrane Database Syst Rev 2013;9:CD005508
   Google Scholar
• Leopold G, Pabst J, Ungethum W, Buhring KU. Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist. J Clin Pharmacol 1986;26:616-21
   PubMed Web of Science ®Google Scholar
• Hostalek U, Uhl W. Data on file. 2.5 Clinical Overview Addendum – Justification on not submitting an interaction study. Merck KGaA. 2012
   Google Scholar
• Lonn EM, Rambihar S, Gao P, et al. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol 2014;103:149-59
   PubMed Web of Science ®Google Scholar